Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-24

FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)